Your Source for Venture Capital and Private Equity Financings

VC-funded Company:

Q32 Bio
One Broadway, 11th Floor
Cambridge, MA 02142
https://www.q32bio.com/

Q32 Bio is a clinical stage biotechnology company developing therapies targeting powerful regulators of the innate and adaptive immune systems to re-balance immunity in severe autoimmune and inflammatory diseases. Q32 Bio's lead programs, focused on the IL-7R pathway and complement system, address immune dysregulation to help patients take back control of their lives.

Key Contact
Name
Michael Broxson
Title
CEO
E-Mail
Funding Events

Date
Amount
Type
Investors
10/29/20 $60,000,000 Series B Acorn Bioventures
OrbiMed Advisors